Humanigen
Utility Patent Applications
Last updated:
List of all Humanigen patents 15 in total
| Status | Patent |
|---|---|
Application | Utility: MATERIALS AND METHODS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: MATERIALS AND METHODS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: EPHA3 ANTIBODIES FOR THE TREATMENT OF PULMONARY FIBROSIS Filling date: 6 Sep 2025 Issue date: 5 Sep 2019 |
Showing 1 to 15 of 15 patents.